Correlation Between Ignyte Acquisition and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both Ignyte Acquisition and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ignyte Acquisition and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ignyte Acquisition Corp and Molecular Partners AG, you can compare the effects of market volatilities on Ignyte Acquisition and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ignyte Acquisition with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ignyte Acquisition and Molecular Partners.
Diversification Opportunities for Ignyte Acquisition and Molecular Partners
-0.62 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Ignyte and Molecular is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Ignyte Acquisition Corp and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Ignyte Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ignyte Acquisition Corp are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Ignyte Acquisition i.e., Ignyte Acquisition and Molecular Partners go up and down completely randomly.
Pair Corralation between Ignyte Acquisition and Molecular Partners
If you would invest 684.00 in Molecular Partners AG on September 1, 2024 and sell it today you would lose (102.00) from holding Molecular Partners AG or give up 14.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 0.27% |
| Values | Daily Returns |
Ignyte Acquisition Corp vs. Molecular Partners AG
Performance |
| Timeline |
| Ignyte Acquisition Corp |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Molecular Partners |
Ignyte Acquisition and Molecular Partners Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ignyte Acquisition and Molecular Partners
The main advantage of trading using opposite Ignyte Acquisition and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ignyte Acquisition position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.| Ignyte Acquisition vs. Akeso, Inc | Ignyte Acquisition vs. Innovation1 Biotech | Ignyte Acquisition vs. Ascletis Pharma | Ignyte Acquisition vs. Avax Techs |
| Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |